Processes for the preparation of ivacaftor

US10501419B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10501419-B2
Application numberUS-201615755436-A
CountryUS
Kind codeB2
Filing dateSep 2, 2016
Priority dateSep 2, 2015
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides processes for the preparation of ivacaftor using novel intermediates and a process for its preparation.

First claim

Opening claim text (preview).

We claim: 1. A process for the preparation of ivacaftor of Formula I or a pharmaceutically acceptable salt thereof, comprising: a1) reacting a compound of Formula VI with a dimethyl formamide-dimethyl amine complex to obtain a compound of Formula VII, wherein ‘X’ represents a halo and ‘R1’ represents either hydrogen or a protecting group; b1) reacting the compound of Formula VII with a source of ammonia to obtain a compound of Formula VIII, c1) cyclizing the compound of Formula VIII to obtain the ivacaftor of Formula I, when R1 is hydrogen, or to obtain a compound of Formula IX, when R1 represents a protecting group and deprotecting the Formula IX in a deprotecting agent to obtain the ivacaftor, 2. The process of claim 1 , wherein when ‘R1’ represents a protecting group, ‘R1’ is selected from the group consisting of methoxycarbonyl, methoxymethyl, benzyloxymethyl, tetrahydropyranyl, benzyl, benzoyl, p-methoxybenzyl, p-nitrobenzyl, o-nitrobenzyl, p-nitrobenzoyl, and trimethylsilyl. 3. The process of claim 1 , wherein ‘X’ represents one of a fluoro, chloro, bromo, or iodo. 4. The process of claim 1 , wherein ‘X’ is fluoro and ‘R1’ represents one of hydrogen and methoxycarbonyl. 5. The process of claim 1 , wherein the step a1) is carried out in presence of an organic solvent. 6. The process of claim 5 , wherein the organic solvent is selected from the group consisting of acetonitrile, propionitrile, tetrahydrofuran, dimethyl ether, methyl tertiary butyl ether, dimethoxyethane, toluene, xylene, and mixtures thereof. 7. The process of claim 1 , wherein the source of ammonia is selected from the group consisting of ammonia gas, ammonium hydroxide, ammonium acetate, and ammonium formate. 8. The process of claim 1 , wherein the step b1) is carried out in presence of a solvent selected from the group consisting of methanol, ethanol, isopropanol, dimethyl formamide, dimethyl acetamide, N-methyl pyrrolidinone, toluene, xylene, water, and mixtures thereof. 9. The process of claim 1 , wherein the cyclization is carried out in presence of a solvent at a temperature of about 25-45° C. 10. The process of claim 9 , wherein the solvent is selected from the group consisting of tetrahydrofuran, 2-methyl tetrahydrofuran, dimethyl ether, methyl tertiary butyl ether, methanol, ethanol, isopropanol, toluene, xylene, dimethylformamide, dimethyl acetamide, N-methyl pyrrolidinone, dimethylsulfoxide, sulfolane, acetonitrile, propionitrile, and mixtures thereof. 11. The process of claim 1 , wherein the step of deprotection is carried out with a deprotecting agent in presence of a solvent. 12. The process of claim 11 , wherein the deprotecting agent is selected from the group consisting of hydrochloric acid, hydrobromic acid, trifluoro acetic acid, sodium hydroxide, sodium ethoxide, and mixtures thereof. 13. The process of claim 11 , wherein the solvent is selected from the group consisting of ethanol, ethanol, isopropanol, acetone, methyl isobutyl ketone, methyl ethyl ketone, tetrahydrofuran, 2-methyl tetrahydrofuran, methyl tertiary butyl ether, dimethyl formamide, dimethylsulfoxide, dimethyl acetamide, N-methyl pyrrolidinone, and mixtures thereof. 14. The process of claim 11 , wherein the deprotecting agent is sodium ethoxide and the solvent is dimethyl formamide.

Assignees

Inventors

Classifications

  • the carbon skeleton containing six-membered aromatic rings · CPC title

  • C07D215/56Primary

    with oxygen atoms in position 4 · CPC title

  • having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides · CPC title

  • Quinolines; Isoquinolines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10501419B2 cover?
The present invention provides processes for the preparation of ivacaftor using novel intermediates and a process for its preparation.
Who is the assignee on this patent?
Laurus Labs Private Ltd, Laurus Labs Ltd
What technology area does this patent fall under?
Primary CPC classification C07D215/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).